A Transdisciplinary Approach to Cannabis Addiction
大麻成瘾的跨学科方法
基本信息
- 批准号:7223240
- 负责人:
- 金额:$ 3.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-29 至 2009-09-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): This application proposes an investigation of a putative endophenotype and candidate genetic variant for cannabis abuse and dependence. A growing body of literature suggests that psychological reactions to the acute effects of marijuana may differ between frequent and infrequent cannabis users. The purpose of the proposed study is to build upon this body of research by investigating the relationship between frequency of marijuana use and subjective reactions to the acute effects of marijuana. A promising candidate genetic locus, the CNR1 SNP, rs2023239, will also be examined, with respect to its relationship to the endophenotype of differential subjective reaction and to its functional significance. Frequent and infrequent cannabis users will be recruited to examine: 1) whether a significant between-group difference in psychological reaction to an acute marijuana administration episode exists, such that frequent users report more positive and fewer negative psychological reactions; 2) whether the effect of the SNP on subjective reaction mediates its effect on frequency of cannabis use; and 3) what the functional significance of the CNR1 SNP is with respect to the function of the cannabinoid receptor gene. Findings will contribute to the development of an endophenotype of cannabis use-related psychopathology. As discussed in the application, problem use of marijuana presents a growing public health problem. Marijuana is the most commonly used illicit drug in the United States and most of the world, and a growing percentage of users now report difficulties in controlling their marijuana use. The proposed research will aid treatment of problem marijuana use by attempting to identify genetic and behavioral markers that make people more likely to develop cannabis abuse or dependence. Knowledge of these markers will allow health care providers to create targeted interventions to treat these disorders.
描述(由申请人提供):本申请提出了一项关于大麻滥用和依赖的推定内表型和候选遗传变异的调查。越来越多的文献表明,经常和不经常使用大麻的人对大麻急性效应的心理反应可能不同。拟议研究的目的是通过调查大麻使用频率与对大麻急性效应的主观反应之间的关系,建立在这一研究基础上。还将检查一个有希望的候选遗传基因座CNR 1 SNP(rs 2023239)与差异主观反应内表型的关系及其功能意义。将招募频繁和不频繁的大麻使用者来检查:1)是否存在对急性大麻给药事件的心理反应的显著组间差异,例如频繁使用者报告更多的积极心理反应和更少的消极心理反应; 2)SNP对主观反应的影响是否介导其对大麻使用频率的影响;以及3)CNR 1 SNP相对于大麻素受体基因的功能的功能意义。研究结果将有助于大麻使用相关精神病理学的内在表型的发展。正如申请中所讨论的,大麻的问题使用提出了一个日益严重的公共卫生问题。大麻是美国和世界大部分地区最常用的非法药物,越来越多的使用者现在报告难以控制他们的大麻使用。这项拟议中的研究将通过试图确定使人们更有可能滥用或依赖大麻的遗传和行为标记来帮助治疗大麻使用问题。这些标志物的知识将使卫生保健提供者能够制定有针对性的干预措施来治疗这些疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH P. SCHACHT其他文献
JOSEPH P. SCHACHT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH P. SCHACHT', 18)}}的其他基金
An exploratory randomized controlled trial of the effects of oral semaglutide on alcohol craving and consumption
口服索马鲁肽对酒精渴望和消费影响的探索性随机对照试验
- 批准号:
10747743 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder
COMT 抑制作为共病酒精使用障碍和注意力缺陷/多动障碍患者的潜在治疗靶点
- 批准号:
9918216 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别:
A pharmacogenetic human laboratory investigation of brexpiprazole in Alcohol Use Disorder
布瑞哌唑治疗酒精使用障碍的药物遗传学人类实验室研究
- 批准号:
10022084 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别:
A pharmacogenetic human laboratory investigation of brexpiprazole in Alcohol Use Disorder
布瑞哌唑治疗酒精使用障碍的药物遗传学人类实验室研究
- 批准号:
10678836 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别:
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder
COMT 抑制作为共病酒精使用障碍和注意力缺陷/多动障碍患者的潜在治疗靶点
- 批准号:
10369711 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别:
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder
COMT 抑制作为共病酒精使用障碍和注意力缺陷/多动障碍患者的潜在治疗靶点
- 批准号:
10597530 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别:
A pharmacogenetic human laboratory investigation of brexpiprazole in Alcohol Use Disorder
布瑞哌唑治疗酒精使用障碍的药物遗传学人类实验室研究
- 批准号:
10231165 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别:
A pharmacogenetic human laboratory investigation of brexpiprazole in Alcohol Use Disorder
布瑞哌唑治疗酒精使用障碍的药物遗传学人类实验室研究
- 批准号:
10473693 - 财政年份:2019
- 资助金额:
$ 3.04万 - 项目类别:
Neural Connectivity and the Transition to Alcohol Dependence
神经连接和酒精依赖的转变
- 批准号:
8733486 - 财政年份:2013
- 资助金额:
$ 3.04万 - 项目类别:
Neural Connectivity and the Transition to Alcohol Dependence
神经连接和酒精依赖的转变
- 批准号:
8509928 - 财政年份:2013
- 资助金额:
$ 3.04万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 3.04万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 3.04万 - 项目类别:














{{item.name}}会员




